XML 80 R26.htm IDEA: XBRL DOCUMENT
v2.4.0.8

FINANCIAL INSTRUMENTS (Tables) | 9 Months Ended
--- | ---
Mar. 30, 2014
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis at March 30, 2014:
|  |  |  |  | Fair Value Measurement at March 30, 2014 |
|  |  |  |  | Quoted Prices in |  |  |  |  |  | Significant |
|  |  |  |  | Active Markets for |  |  | Significant Other |  |  | Unobservable |
|  |  |  |  | Identical Assets |  |  | Observable Inputs |  |  | Inputs |
|  | Total |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-Term Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | 1,042,596 |  |  | $ | 1,042,596 |  |  | $ | — |  |  | $ | — |
Municipal Notes and Bonds |  |  | 248,949 |  |  |  | — |  |  |  | 248,949 |  |  |  | — |
US Treasury and Agencies |  |  | 182,967 |  |  |  | 182,967 |  |  |  | — |  |  |  | — |
Government-Sponsored Enterprises |  |  | 41,089 |  |  |  | — |  |  |  | 41,089 |  |  |  | — |
Foreign Government Bonds |  |  | 34,988 |  |  |  | — |  |  |  | 34,988 |  |  |  | — |
Corporate Notes and Bonds |  |  | 961,378 |  |  |  | 132,549 |  |  |  | 828,829 |  |  |  | — |
Mortgage Backed Securities - Residential |  |  | 26,580 |  |  |  | — |  |  |  | 26,580 |  |  |  | — |
Mortgage Backed Securities - Commercial |  |  | 104,857 |  |  |  | — |  |  |  | 104,857 |  |  |  | — |
Total Short-Term Investments |  | $ | 2,643,404 |  |  | $ | 1,358,112 |  |  | $ | 1,285,292 |  |  | $ | — |
Mutual Funds |  |  | 28,559 |  |  |  | 28,559 |  |  |  | — |  |  |  | — |
Derivative Assets |  |  | 2,487 |  |  |  | — |  |  |  | 2,487 |  |  |  | — |
Total Assets |  | $ | 2,674,450 |  |  | $ | 1,386,671 |  |  | $ | 1,287,779 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative Liabilities |  | $ | 1,340 |  |  | $ | — |  |  | $ | 1,190 |  |  | $ | 150 |
The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis at June 30, 2013:
|  |  |  |  | Fair Value Measurement at June 30, 2013 |
|  | Total |  |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-Term Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | 725,311 |  |  | $ | 725,311 |  |  | $ | — |  |  | $ | — |
Municipal Notes and Bonds |  |  | 268,746 |  |  |  | — |  |  |  | 268,746 |  |  |  | — |
US Treasury and Agencies |  |  | 155,293 |  |  |  | 155,293 |  |  |  | — |  |  |  | — |
Government-Sponsored Enterprises |  |  | 54,805 |  |  |  | — |  |  |  | 54,805 |  |  |  | — |
Foreign Government Bond |  |  | 24,972 |  |  |  | — |  |  |  | 24,972 |  |  |  | — |
Corporate Notes and Bonds |  |  | 860,492 |  |  |  | 164,885 |  |  |  | 695,607 |  |  |  | — |
Mortgage Backed Securities - Residential |  |  | 27,365 |  |  |  | — |  |  |  | 27,365 |  |  |  | — |
Mortgage Backed Securities - Commercial |  |  | 107,958 |  |  |  | — |  |  |  | 107,958 |  |  |  | — |
Total Short-Term Investments |  | $ | 2,224,942 |  |  | $ | 1,045,489 |  |  | $ | 1,179,453 |  |  | $ | — |
Equities |  |  | 7,096 |  |  |  | 7,096 |  |  |  | — |  |  |  | — |
Mutual Funds |  |  | 18,216 |  |  |  | 18,216 |  |  |  | — |  |  |  | — |
Derivative Assets |  |  | 4,929 |  |  |  | — |  |  |  | 4,929 |  |  |  | — |
Total Assets |  | $ | 2,255,183 |  |  | $ | 1,070,801 |  |  | $ | 1,184,382 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative Liabilities |  | $ | 1,815 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | 195 |
Schedule of Assets and Liabilities Measured at Fair Value as Reported in Consolidated Balance Sheet | The amounts in the table above are reported in the Consolidated Balance Sheet as of March 30, 2014 as follows:
Reported Within: |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
|  | (In thousands) |
Cash Equivalents |  | $ | 1,042,596 |  |  | $ | 1,042,596 |  |  | $ | — |  |  | $ | — |
Short-Term Investments |  |  | 1,462,171 |  |  |  | 176,879 |  |  |  | 1,285,292 |  |  |  | — |
Restricted Cash and Investments |  |  | 138,637 |  |  |  | 138,637 |  |  |  | — |  |  |  | — |
Prepaid Expenses and Other Current Assets |  |  | 2,487 |  |  |  | — |  |  |  | 2,487 |  |  |  | — |
Other Assets |  |  | 28,559 |  |  |  | 28,559 |  |  |  | — |  |  |  | — |
Total Assets |  | $ | 2,674,450 |  |  | $ | 1,386,671 |  |  | $ | 1,287,779 |  |  | $ | — |
Accrued Expenses and Other Current Liabilities |  | $ | 1,190 |  |  | $ | — |  |  | $ | 1,190 |  |  | $ | — |
Other Non-current Liabilities |  |  | 150 |  |  |  | — |  |  |  | — |  |  |  | 150 |
Total Liabilities |  | $ | 1,340 |  |  | $ | — |  |  | $ | 1,190 |  |  | $ | 150 |
The amounts in the table above are reported in the Consolidated Balance Sheet as of June 30, 2013 as follows:
Reported Within: |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
|  | (In thousands) |
Cash Equivalents |  | $ | 725,311 |  |  | $ | 725,311 |  |  | $ | — |  |  | $ | — |
Short-Term Investments |  |  | 1,334,746 |  |  |  | 155,293 |  |  |  | 1,179,453 |  |  |  | — |
Restricted Cash and Investments |  |  | 164,885 |  |  |  | 164,885 |  |  |  | — |  |  |  | — |
Prepaid Expenses and Other Current Assets |  |  | 4,929 |  |  |  | — |  |  |  | 4,929 |  |  |  | — |
Other Assets |  |  | 25,312 |  |  |  | 25,312 |  |  |  | — |  |  |  | — |
Total Assets |  | $ | 2,255,183 |  |  | $ | 1,070,801 |  |  | $ | 1,184,382 |  |  | $ | — |
Accrued Expenses and Other Current Liabilities |  | $ | 1,620 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | — |
Other Non-current Liabilities |  |  | 195 |  |  |  | — |  |  |  | — |  |  |  | 195 |
Total Liabilities |  | $ | 1,815 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | 195 |
Summary of Investments | The following tables summarize the Company’s investments:
|  | March 30, 2014 |  |  | June 30, 2013 |
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Value |  |  | Cost |  |  | Unrealized Gain |  |  | Unrealized Loss |  |  | Fair Value |
|  | (In thousands) |  |  | (In thousands) |
Cash |  | $ | 254,982 |  |  | $ | — |  |  | $ | — |  |  | $ | 254,982 |  |  | $ | 438,813 |  |  | $ | — |  |  | $ | — |  |  | $ | 438,813 |
Fixed Income Money Market Funds |  |  | 1,042,596 |  |  |  | — |  |  |  | — |  |  |  | 1,042,596 |  |  |  | 725,311 |  |  |  | — |  |  |  | — |  |  |  | 725,311 |
Municipal Notes and Bonds |  |  | 248,050 |  |  |  | 927 |  |  |  | (28 | ) |  |  | 248,949 |  |  |  | 268,390 |  |  |  | 805 |  |  |  | (449 | ) |  |  | 268,746 |
US Treasury and Agencies |  |  | 183,072 |  |  |  | 61 |  |  |  | (166 | ) |  |  | 182,967 |  |  |  | 155,648 |  |  |  | 18 |  |  |  | (373 | ) |  |  | 155,293 |
Government-Sponsored Enterprises |  |  | 41,068 |  |  |  | 51 |  |  |  | (30 | ) |  |  | 41,089 |  |  |  | 54,835 |  |  |  | 65 |  |  |  | (95 | ) |  |  | 54,805 |
Foreign Government Bonds |  |  | 34,979 |  |  |  | 95 |  |  |  | (86 | ) |  |  | 34,988 |  |  |  | 24,950 |  |  |  | 47 |  |  |  | (25 | ) |  |  | 24,972 |
Corporate Notes and Bonds |  |  | 960,356 |  |  |  | 1,771 |  |  |  | (749 | ) |  |  | 961,378 |  |  |  | 861,109 |  |  |  | 1,328 |  |  |  | (1,945 | ) |  |  | 860,492 |
Mortgage Backed Securities - Residential |  |  | 26,802 |  |  |  | 30 |  |  |  | (252 | ) |  |  | 26,580 |  |  |  | 27,618 |  |  |  | 29 |  |  |  | (282 | ) |  |  | 27,365 |
Mortgage Backed Securities - Commercial |  |  | 105,264 |  |  |  | 141 |  |  |  | (548 | ) |  |  | 104,857 |  |  |  | 108,204 |  |  |  | 426 |  |  |  | (672 | ) |  |  | 107,958 |
Total Cash and Short -Term Investments |  | $ | 2,897,169 |  |  | $ | 3,076 |  |  | $ | (1,859 | ) |  | $ | 2,898,386 |  |  | $ | 2,664,878 |  |  | $ | 2,718 |  |  | $ | (3,841 | ) |  | $ | 2,663,755 |
Publicly Traded Equity Security |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5,610 |  |  | $ | 1,486 |  |  | $ | — |  |  | $ | 7,096 |
Private Equity Security |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,000 |  |  |  | — |  |  |  | — |  |  |  | 5,000 |
Mutual Funds |  |  | 25,656 |  |  |  | 2,903 |  |  |  | — |  |  |  | 28,559 |  |  |  | 16,611 |  |  |  | 1,619 |  |  |  | (14 | ) |  |  | 18,216 |
Total Financial Instruments |  | $ | 2,922,825 |  |  | $ | 5,979 |  |  | $ | (1,859 | ) |  | $ | 2,926,945 |  |  | $ | 2,692,099 |  |  | $ | 5,823 |  |  | $ | (3,855 | ) |  | $ | 2,694,067 |
Reported Within |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and Cash Equivalents |  | $ | 1,292,301 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,292,301 |  |  | $ | 1,162,473 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,162,473 |
Short-Term Investments |  |  | 1,460,954 |  |  |  | 3,076 |  |  |  | (1,859 | ) |  |  | 1,462,171 |  |  |  | 1,335,868 |  |  |  | 2,718 |  |  |  | (3,841 | ) |  |  | 1,334,745 |
Restricted Cash and Investments |  |  | 143,914 |  |  |  | — |  |  |  | — |  |  |  | 143,914 |  |  |  | 166,536 |  |  |  | — |  |  |  | — |  |  |  | 166,536 |
Other assets |  |  | 25,656 |  |  |  | 2,903 |  |  |  | — |  |  |  | 28,559 |  |  |  | 27,222 |  |  |  | 3,105 |  |  |  | (14 | ) |  |  | 30,313 |
Total |  | $ | 2,922,825 |  |  | $ | 5,979 |  |  | $ | (1,859 | ) |  | $ | 2,926,945 |  |  | $ | 2,692,099 |  |  | $ | 5,823 |  |  | $ | (3,855 | ) |  | $ | 2,694,067 |
Schedule of Fixed Income Securities in Unrealized Loss Positions | The following is an analysis of the Company’s fixed income securities in unrealized loss positions:
|  | March 30, 2014 |
|  | Unrealized Losses |  |  | Unrealized Losses |  |  |  |  |  |  |
|  | Less Than 12 Months |  |  | 12 Months or Greater |  |  | Total |
|  | Fair Value |  |  | Gross Unrealized Loss |  |  | Fair Value |  |  | Gross Unrealized Loss |  |  | Fair Value |  |  | Gross Unrealized Loss |
|  | (In thousands) |
Short-Term Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Municipal Notes and Bonds |  | $ | 17,114 |  |  | $ | (28 | ) |  | $ | — |  |  | $ | — |  |  | $ | 17,114 |  |  | $ | (28 | )
US Treasury and Agencies |  |  | 96,394 |  |  |  | (166 | ) |  |  | — |  |  |  | — |  |  |  | 96,394 |  |  |  | (166 | )
Government-Sponsored Enterprises |  |  | 14,071 |  |  |  | (30 | ) |  |  | — |  |  |  | — |  |  |  | 14,071 |  |  |  | (30 | )
Foreign Government Bonds |  |  | 18,487 |  |  |  | (86 | ) |  |  | — |  |  |  | — |  |  |  | 18,487 |  |  |  | (86 | )
Corporate Notes and Bonds |  |  | 261,299 |  |  |  | (729 | ) |  |  | 6,465 |  |  |  | (20 | ) |  |  | 267,764 |  |  |  | (749 | )
Mortgage Backed Securities - Residential |  |  | 20,974 |  |  |  | (243 | ) |  |  | 127 |  |  |  | (9 | ) |  |  | 21,101 |  |  |  | (252 | )
Mortgage Backed Securities - Commercial |  |  | 75,081 |  |  |  | (404 | ) |  |  | 4,249 |  |  |  | (144 | ) |  |  | 79,330 |  |  |  | (548 | )
Total Short-Term Investments |  | $ | 503,420 |  |  | $ | (1,686 | ) |  | $ | 10,841 |  |  | $ | (173 | ) |  | $ | 514,261 |  |  | $ | (1,859 | )
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Short-Term Investments, and Restricted Cash and Investments with Contractual Maturities | The amortized cost and fair value of cash equivalents, short-term investments, and restricted cash and investments with contractual maturities are as follows as of March 30, 2014:
|  | Cost |  |  | Estimated Fair Value |
|  | (in thousands) |
Due in one year or less |  | $ | 1,316,589 |  |  | $ | 1,317,140 |
Due after one year through five years |  |  | 1,035,559 |  |  |  | 1,036,852 |
Due in more than five years |  |  | 290,039 |  |  |  | 289,412 |
|  | $ | 2,642,187 |  |  | $ | 2,643,404 |
Schedule of Outstanding Foreign Currency Forward Contracts | As of March 30, 2014, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program:
|  | Derivatives Designated as |  |  | Derivatives Not Designated as |
|  | Hedging Instruments: |  |  | Hedging Instruments: |
|  | (in thousands) |
Foreign Currency Forward Contracts |  |  |  |  |  |  |  |  |  |  |  |
|  | Buy Contracts |  |  | Sell Contracts |  |  | Buy Contracts |  |  | Sell Contracts |
Japanese Yen |  | $ | — |  |  | $ | 123,282 |  |  | $ | — |  |  | $ | 65,959 |
Swiss Franc |  |  |  |  |  |  |  |  |  |  | 7,496 |  |  |  | — |
Euro |  |  | 60,487 |  |  |  | — |  |  |  | — |  |  |  | 8,901 |
Korean Won |  |  | — |  |  |  | — |  |  |  | 36,386 |  |  |  | — |
Taiwan Dollar |  |  | — |  |  |  | — |  |  |  | 188,583 |  |  |  | 65,899 |
|  | $ | 60,487 |  |  | $ | 123,282 |  |  | $ | 232,465 |  |  | $ | 140,759 |
Schedule of Fair Value of Derivatives Instruments | The fair value of derivative instruments in the Company’s Consolidated Balance Sheets as of March 30, 2014 and June 30, 2013 were as follows:
|  | March 30, 2014 |  |  | June 30, 2013 |
|  | Fair Value of Derivative Instruments |  |  | Fair Value of Derivative Instruments |
|  | Asset Derivatives |  |  | Liability Derivatives |  |  | Asset Derivatives |  |  | Liability Derivatives |
|  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |
|  | (in thousands) |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  | Prepaid expense and other assets |  | $ | 2,297 |  |  | Accrued liabilities |  | $ | 619 |  |  | Prepaid expense and other assets |  | $ | 4,858 |  |  | Accrued liabilities |  | $ | 1,577 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  | Prepaid expense and other assets |  |  | 190 |  |  | Accrued liabilities |  |  | 571 |  |  | Prepaid expense and other assets |  |  | 71 |  |  | Accrued liabilities |  |  | 43 |
Total derivatives |  |  |  | $ | 2,487 |  |  |  |  | $ | 1,190 |  |  |  |  | $ | 4,929 |  |  |  |  | $ | 1,620 |
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income ("AOCI") | The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:
|  | Three Months Ended March 30, 2014 |  |  | Nine Months Ended March 30, 2014 |
|  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |  |  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |
Location of Gain (Loss) Recognized in or Reclassified into Income |  | Gain (Loss) Recognized in AOCI |  |  | Gain Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |  |  | Gain Recognized in AOCI |  |  | Gain Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |
|  | (in thousands) |  |  | (in thousands) |
Revenue |  | $ | (621 | ) |  | $ | 2,787 |  |  | $ | 54 |  |  | $ | 7,483 |  |  | $ | 8,947 |  |  | $ | 232 |
Cost of goods sold |  |  | 307 |  |  |  | 646 |  |  |  | (10 | ) |  |  | 1,717 |  |  |  | 1,764 |  |  |  | (66 | )
Selling, general, and administrative |  |  | 112 |  |  |  | 291 |  |  |  | (5 | ) |  |  | 667 |  |  |  | 800 |  |  |  | (29 | )
Other income (expense) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
|  | $ | (202 | ) |  | $ | 3,724 |  |  | $ | 39 |  |  | $ | 9,867 |  |  | $ | 11,511 |  |  | $ | 137 |
|  | Three Months Ended March 31, 2013 |  |  | Nine Months Ended March 31, 2013 |
|  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |  |  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |
Location of Gain (Loss) Recognized in or Reclassified into Income |  | Gain (Loss) Recognized in AOCI |  |  | Gain Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |  |  | Gain Recognized in AOCI |  |  | Gain (Loss) Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |
|  | (in thousands) |  |  | (in thousands) |
Revenue |  | $ | 9,454 |  |  | $ | 3,850 |  |  | $ | 78 |  |  | $ | 8,159 |  |  | $ | 4,574 |  |  | $ | 274 |
Cost of goods sold |  |  | (563 | ) |  |  | 1,194 |  |  |  | (44 | ) |  |  | 1,332 |  |  |  | (1,069 | ) |  |  | (208 | )
Selling, general, and administrative |  |  | (491 | ) |  |  | 345 |  |  |  | (20 | ) |  |  | 537 |  |  |  | (405 | ) |  |  | (100 | )
Other income (expense) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (8 | )
|  | $ | 8,400 |  |  | $ | 5,389 |  |  | $ | 14 |  |  | $ | 10,028 |  |  | $ | 3,100 |  |  | $ | (42 | )
The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:
|  |  |  | Three Months Ended |  |  | Nine Months Ended |
|  |  |  | March 30, 2014 |  |  | March 31, 2013 |  |  | March 30, 2014 |  |  | March 31, 2013 |
Derivatives Not Designated as Hedging Instruments: |  | Location of Gain (Loss) Recognized in Income |  | Loss Recognized in Income |  |  | Gain Recognized in Income |  |  | Gain Recognized in Income |  |  | Gain Recognized in Income |
|  |  |  | (in thousands) |
Foreign Exchange Contracts |  | Other income (expense) |  | $ | (6,527 | ) |  | $ | 2,061 |  |  | $ | 4,512 |  |  | $ | 2,347 |

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13467-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13476-108611 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. + References No definition available. + Details
Name: | us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the notional amounts of outstanding derivative positions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959 + Details
Name: | us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investments in an unrealized loss position for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), including: (a) the aggregate related fair value of investments with unrealized losses, (b) the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563 + Details
Name: | us-gaap_ScheduleOfTemporaryImpairmentLossesInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of unrealized gains and losses on investments. + References No definition available. + Details
Name: | us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration